Margarida Pujol Lopez

Scientist University of Arizona Phoenix @uazmedphx 🇺🇸| Cardiologist EP 🇪🇸| MD PhD MSc | GCSRT @Harvardmed| RioHortega | Acadèmica RAMC

[Margarida Pujol Lopez @MargaridaPujol]

University of Arizona Cardiology EP Team
All great things take time 🙏
If you want to go fast go alone; If you want to go far go together ♥️

https://t.co/sN6szFRaF9

[Margarida Pujol Lopez @MargaridaPujol]

University of Arizona EP @DrRoderickTung @su_wilber @Peteweissmd @MikeZawanehMD @bairong74 @DrKatrapati @JakeCMartinez @NaohikoSahara @Noozie2 @dalise_sz et al 🙏🫶
#HRS25 San Diego

Busy 4d for the TEAM

If you want to go fast go alone; If you want to go far go together ♥️

[Bartosz Hudzik MD PhD FESC FACC @BartoszHudzik]

🫀#ESCCongress wraps in Munich with practice-shaping trials. Cardiology keeps moving fast. #Cardiology #CardioTwitter #CardioEd @escardio @ESC_President @CMichaelGibson @JGrapsa @drjohnm @DrMarthaGulati @ErinMichos @mirvatalasnag @Drroxmehran @DFCapodanno @DLBHATTMD

[Omar Kreidieh @OmarKreidieh1]

@drjohnm Agreed. You can't handicap a control arm by preventing a therapy that is available in the real world to people not receiving ablation. BUT the findings are almost certainly type 2 error. You do enough trials on a beneficial treatment and some will be negative

[EHRAPresident @EHRAPresident]

Who is behind #EHRA_ESC? 👋❤️

The new EHRA Board brings together colleagues working across the many areas that make our community thrive:

🎓 Education
🔬 Science
❤️ Patient initiatives
🤖 Digital & AI
🌍 Diversity & international collaboration
🧬 Genetics
🌱 Young EP
📣 Advocacy & communication
🎤 Congress & more
And behind them? Committees, volunteers and members sharing their expertise, energy and ideas. 🤝
EHRA is much more than its President or Board — it’s a diverse, international community working together to shape the future of electrophysiology. ⚡🌍❤️

#EHRATopicWeek #EHRA_ESC #EHRAEducation #ScientificInitiatives #DigitalHealth #PatientInitiatives #YoungEP #ECommunications #EHRA2027 #Leadership #Electrophysiology

[Medtronic Cardiac @MDT_Cardiac]

The Medtronic Empowering EP program allows women to advocate for and support other women as they progress through cardiology fellowship, sharing with them the world of EP. Apply by September 8 to join us in this year’s program. #Epeeps
Register today: https://t.co/QB4pZyhd0O

[Enrico Ferro, MD @enricoferroMD]

Thrilled to share our latest study in @CircAHA: we ran one of the largest comparative safety analyses of #PFA vs radiofrequency #ablation for #AF, performed
@BIDMChealth (>1,500 #PVI/year). We found a significantly higher stroke risk with PFA. Read on👇

https://t.co/sFECm0SFaY

[European Society of Cardiology @escardio]

New approaches to Atrial Fibrillation, Dyslipedaemias and Hypertension - Hot Line 8 & 9 👇

More #ESCCongress 2026 Hot Lines visual summaries are available here: https://t.co/UTqnyBqabR

#ESCCongress

[Milan Koštek @KostekMilan]

🫀 HIS Alternative II 🫀

[Prof Catherine Ross @catherinemross]

Great to attend the ESC General Assembly and hear @LindeCecilia set out her vision for her presidency

I’m pleased to see such ambition around the EU Safe Hearts Plan alongside a strong focus on workforce, diversity, inclusion and professional wellbeing.

#ESCCongress2026

[Margarida Pujol Lopez @MargaridaPujol]

HIS ALTERNATIVE II by Dr Vinther 🇩🇰and Team. JACCEP

CSP vs BiVP in LBBB (Strauss). Non inferiority decreasing LVESV for CSP 🌿 at 6-month FU

Random 1:2; 15% cross for CSP

Congrats💚 @MvintherVinther @ZacharyWhinnett

https://t.co/ZKJwggA3gz

@JACCJournals

[Michael Vinther @MvintherVinther]

The HIS Alternative II study is now available in JACC-EP:

https://t.co/UoBVInTYsJ

[NEJM @NEJM]

Original Article: Complete Revascularization Guided by Functional Coronary Angiography in STEMI (AIR-STEMI trial) https://t.co/8N0VqHwVwC

#ESCCongress | @escardio

[John Mandrola, MD @drjohnm]

RE: SHAM-PVI-AF
yes, I agree with my friend, but...but...a) the other sham trials also included cardioversion, b) neither trial actually includes a proper sham, which would include transeptal puncture and sheath dilation.

IMO, the main take-homes are to ALWAYS question our beliefs, and, to be humble about the correlation between what is on an ECG and symptoms, and, finally, be way more conservative about ablation in the first place

[Margarida Pujol Lopez @MargaridaPujol]

@JlmontGirbau Congrats Mont ❣️!

[European Society of Cardiology @escardio]

Advances in Cardiac Arrest, Coronary Imaging and Interventional Cardiology - Hot Line 12👇

More #ESCCongress 2026 Hot Lines visual summaries are available here: https://t.co/UTqnyBqabR

#ESCCongress

[European Society of Cardiology @escardio]

Advances in Cardiac Arrest, Coronary Imaging and Interventional Cardiology - Hot Line 10 & 11👇

More #ESCCongress 2026 Hot Lines visual summaries are available here: https://t.co/UTqnyBqabR

#ESCCongress

[Nassir Marrouche @nmarrouche]

Important PVI-SHAM-AF trial—but interpretation matters. This was not ablation vs “nothing.” The sham arm included deep sedation, an invasive cath-lab procedure, intensive follow-up and, importantly, cardioversion when patients were in AF—itself an effective rhythm-control intervention.

Yet ablation still produced substantially better rhythm control (73% vs 52% freedom from AF).

With QoL assessed at only 6 months, are we measuring the effect of ablation—or comparing two active rhythm-control strategies?

I would be cautious concluding that ablation does not improve symptoms. The study may instead demonstrate how difficult it is to design a truly inert sham for AF.

#AFib #CatheterAblation #RhythmControl #PVI #ESCCongress @PrashSanders @drjohnm @chris_sohns @peterkistler3 @DJ_Lakkireddy @DrRoderickTung @TinaBaykaner @DrJasonAndrade @SteffelJ @netta_doc @TulaneHeart

[Margarida Pujol Lopez @MargaridaPujol]

@CMichaelGibson @MvintherVinther congrats 🙂

[C. Michael Gibson MD @CMichaelGibson]

In patients with HFrEF who were candidates for cardiac resynchronization therapy (CRT), conduction system pacing (CSP-CRT)—using His bundle or left bundle branch pacing—was non-inferior to biventricular pacing (BiV-CRT) for the relative reduction in left ventricular end-systolic volume (LVESV) at 6 months. Download slides here: https://t.co/op611JJuGt

[Margarida Pujol Lopez @MargaridaPujol]

@JlmontGirbau Els homes?

[C. Michael Gibson MD @CMichaelGibson]

Dr. Michael Vinther and Dr. C. Michael Gibson discuss the His-Alternative II trial: CRT delivered via CSP was non-inferior to conventional biventricular pacing with respect to left ventricular reverse remodeling in patients with symptomatic HF, LVEF ≤35%, LBBB on optimal medical therapy. Watch video here: https://t.co/9D79FNwDrZ

[C. Michael Gibson MD @CMichaelGibson]

SyncAV trial: Automatic dynamic AV delay optimization did not significantly improve the reduction in 12-month LVESV compared with standard fixed programming in patients with LBBB and HF. Download slides here: https://t.co/YEk0rOUaAp